Weekly Stocktake

Roche – Recovering Post Covid

Key Indicators
Index / Fund / Rate
Start of Year
Last Week
This Week
% Change YTD
Index / Fund / Rate
Lunar BCI WW Flexible Fund
Start of Year
141.43
Last Week
175.19
This Week
170.40
% Change YTD
20.48% Lunar Capital increasesymbol
Index / Fund / Rate
JSE ALSI
Start of Year
73 049
Last Week
70 198
This Week
69 452Lunar Capital stocktake arrow down
% Change YTD
-4.92% Lunar Capital stocktake arrow down
Index / Fund / Rate
NASDAQ Composite
Start of Year
10 467
Last Week
12 984
This Week
12 643 Lunar Capital stocktake arrow down
% Change YTD
20.80% Lunar Capital increasesymbol
Index / Fund / Rate
S&P 500
Start of Year
3 840
Last Week
4 224
This Week
4 117 Lunar Capital stocktake arrow down
% Change YTD
7.21% Lunar Capital increasesymbol
Index / Fund / Rate
Prime Lending Rate
Start of Year
10.50%
Last Week
11.75%
This Week
11.75%
% Change YTD
11.90% Lunar Capital increasesymbol
Index / Fund / Rate
USD/ZAR
Start of Year
16.98
Last Week
19.03
This Week
18.84 Lunar Capital stocktake arrow down
% Change YTD
10.95% Lunar Capital increasesymbol
Index / Fund / Rate
EUR/ZAR
Start of Year
18.44
Last Week
20.15
This Week
19.91 Lunar Capital stocktake arrow down
% Change YTD
7.97% Lunar Capital increasesymbol
Index / Fund / Rate
Brent Crude ($'barrel)
Start of Year
85.95
Last Week
92.16
This Week
90.01 Lunar Capital stocktake arrow down
% Change YTD
4.72%Lunar Capital increasesymbol
Source: Iress

Roche is a Swiss-based biotechnology company, specialising in diagnostics and pharmaceuticals.

In diagnostics, Roche has solutions for diagnosis kits for cardiometabolic, diabetes, cancer, and other diseases. Diagnosing diseases early or before they occur in susceptible people, can improve treatments choices, treatment outcomes, reduce suffering, and increase lifespans in patients.

In pharmaceuticals, Roche has treatments for haematology (blood diseases), oncology (cancer), ophthalmology (eye diseases), respiratory, and women’s diseases, amongst others.  

In summary, for the comparative 9 months to end September; Roche revenues were down 6% to ƒ44.1bn (Swiss francs), with Pharmaceuticals up by 1% and Diagnostics down by 25%; in 2023 versus 2022. The main reasons for the decline and low growth in revenues is due to almost zero demand for Covid-19 related diagnostic kits and treatments.

Encouragingly, the uptake of new medicines and diagnostics showed strong growth in both the divisions. Roche also have launches of several products in the fourth quarter and into next year.

  • Vabysmo, a treatment for specific conditions leading to a loss or deterioration of vision was launched in 2022 and is expected to become a blockbuster drug, with sales exceeding ƒ2bn in 2023.
  • Polivy, launched in 2019, and used in the treatment of lymphoma (cancer) has also shown significant in sales growth in 2023.
  • Roche’s Elecsys IL-6 is used in diagnosing sepsis in neonates (new borns) allowing early treatment that can prevent deaths in approximately 84% of cases.

Roche has invested in technology and use AI/ML (Artificial Intelligence/Machine Learning) tools in several areas of their business, including in research and development, clinical development, manufacturing, and commercialisation.  

Biotechnology businesses are subject to strict regulations and are required to get approvals from every country’s regulatory authority to be able to sell their products in those countries. Work in research and development for specific mdeicines can take many years and there is no guarantee of success.

Roche is held by Lunar Capital’s Offshore Portfolio clients and in the Lunar BCI Worldwide Flexible Fund.

Click here to access your account to view statements, obtain tax certificates, add or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

Roche – Recovering Post Covid Read More »

ASML – Riding the Cycle

Advanced Semiconductor Materials Lithography (now renamed simply ASML), is based in cycling country, The Netherlands and released their FY2023 Q3 results on Wednesday last week.

ASML manufactures the lithography equipment to mass produce semiconductor or more commonly called computer chips. Lithography allows one to “print” complex circuits onto silicone wafers creating a semiconductor chip. The process and materials used is highly complex and requires a very high level of precision.

In this last quarter, AMSL experienced a slowdown in new orders, after the significant growth post the Covid-19 slump and the significant take-up following the AI hype. However, ASML expects a significant increase their revenues in 2025.

Let’s look at ASML’s FY2023 Q3 results:

Sales
€6,673bn
Decreased by 3.33% since the last quarter.
No. of Units sold
105 new units
7 used units
Lower by 2 new and 1 used unit since the last quarter.
Gross Profit
€3,462bn
Decreased by 2.31% since the last quarter.
Gross Margin
51.9%
Up from 51.3% since the last quarter.
Net Income
€1,893bn
Decreased by 2.52% since the last quarter.
Net Margin
28.4%
Up from 28.14% since the last quarter.

Despite the slowdown in sales and profits, ASML is still highly profitable and still earns high margins. ASML is almost a monopoly in developing Extreme Ultraviolet Lithography (EUV) technology required to develop smaller (very, very tiny) but more powerful semiconductors or chips.

ASML’s largest client is TSMC (Taiwan Semiconductor Manufacturing Company) who is currently building new factories (or fabs as they are called) in the USA and Germany. This is to mitigate the tensions between the USA and China. In fact, just last week the Biden administration introduced stricter curbs on exporting advanced semiconductor to China. These new fabs will require AMML’s EUV and DUV (Deep Ultraviolet) lithography equipment to mass produce chips at these fabs. Hence, ASML’s positive view of significant increase in sales and profits in 2025.

The semiconductor industry is cyclical and subject to export restrictions.

ASML is held by Lunar Capital’s Offshore Portfolio clients and in the Lunar BCI Worldwide Flexible Fund.

Key Indicators
Index / Fund / Rate
Start of Year
Last Week
This Week
% Change YTD
Index / Fund / Rate
Lunar BCI WW Flexible Fund
Start of Year
141.43
Last Week
176.11
This Week
175.19
% Change YTD
23.87% Lunar Capital increasesymbol
Index / Fund / Rate
JSE ALSI
Start of Year
73 049
Last Week
72 920
This Week
70 198 Lunar Capital stocktake arrow down
% Change YTD
-3.90% Lunar Capital stocktake arrow down
Index / Fund / Rate
NASDAQ Composite
Start of Year
10 467
Last Week
13 407
This Week
12 984 Lunar Capital stocktake arrow down
% Change YTD
24.05% Lunar Capital increasesymbol
Index / Fund / Rate
S&P 500
Start of Year
3 840
Last Week
4 328
This Week
4224 Lunar Capital stocktake arrow down
% Change YTD
10.0% Lunar Capital increasesymbol
Index / Fund / Rate
Prime Lending Rate
Start of Year
10.50%
Last Week
11.75%
This Week
11.75%
% Change YTD
11.90% Lunar Capital increasesymbol
Index / Fund / Rate
USD/ZAR
Start of Year
16.98
Last Week
19.01
This Week
19.03 Lunar Capital increasesymbol
% Change YTD
12.07% Lunar Capital increasesymbol
Index / Fund / Rate
EUR/ZAR
Start of Year
18.44
Last Week
19.98
This Week
20.15 Lunar Capital increasesymbol
% Change YTD
9.27% Lunar Capital increasesymbol
Index / Fund / Rate
Brent Crude ($'barrel)
Start of Year
85.95
Last Week
91.12
This Week
92.16 Lunar Capital increasesymbol
% Change YTD
7.23%Lunar Capital increasesymbol
Source: Iress

Click here to access your account to view statements, obtain tax certificates, add or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

ASML – Riding the Cycle Read More »

Birken’s Stock

Birken’s Stock

Last week, Birkenstock Holding, along with the majority-shareholder private-equity firm L Catterton, raised approximately $1.5 billion through an initial public offering (IPO) for the German shoe brand, Birkenstock. About one-third of the proceeds were allocated towards alleviating some of Birkenstock’s existing debt, while the remaining portion was distributed to L Catterton. Birkenstock was valued at $9.3 billion, with an IPO price of $46 per share.

Birkenstock, founded in 1774 and known for their iconic cork-based sandals, had a majority stake acquired by L Catterton in 2021. It valued the company at $4.8 billion at the time. L Catterton, backed by LVMH (the luxury brand conglomerate,) said they bought the stake with the intention of increasing Birkenstock’s presence in India and China; and also increasing its direct-to-consumer segment. Between 2020 and 2022 fiscal year-end, sales for Birkenstock increased from $771 million to $1.24 billion, with direct-to-consumer sales making up 38% of the sales in 2022.

In addition to prioritizing direct-to-consumer sales, the company has developed strategic collaborations with luxury fashion labels like Dior and Manolo Blahnik. These co-branded shoes, despite selling far less in terms of volume, command much higher prices (and higher gross margins). Some of these co-branded sandals can go for us much as €1600; while Birkenstock’s standard models, like the Barbados, are priced at approximately €45.

One of the reasons Birkenstock sandals are popular is because they are designed to distribute your body weight throughout your entire foot, rather than on specific pressure points like your heels or balls of your feet. They are also adjustable for different foot widths and the cork footbed gets moulded to the shape of your foot. Originally developed as orthopaedic shoes, Birkenstocks now have a cult like following, and were featured in the recent Barbie movie which has led to further interest in the brand.

Birkenstock’s shares fell by over 20% last week from its IPO price. IPO’s are used to raise capital for growth initiatives, debt settlement, or to provide liquidity to the shareholder base. Private-equity firms often use IPO’s to realise value from an investment that they made in a company. This often leads to large tranches of shares being available in the market post the IPO: resulting in a drop in the share price. This is one of the reasons that we, at Lunar Capital, generally avoid buying shares in a company when it IPO’s.

LVMH is held by Lunar Capital’s Offshore Portfolio clients.

Key Indicators
Index / Fund / Rate
Start of Year
Last Week
This Week
% Change YTD
Index / Fund / Rate
Lunar BCI WW Flexible Fund
Start of Year
141.43
Last Week
176.38
This Week
177.11
% Change YTD
25.23% Lunar Capital increasesymbol
Index / Fund / Rate
JSE ALSI
Start of Year
73 049
Last Week
71 657
This Week
72 920 Lunar Capital increasesymbol
% Change YTD
-0.18% Lunar Capital stocktake arrow down
Index / Fund / Rate
NASDAQ Composite
Start of Year
10 467
Last Week
13 431
This Week
13 407 Lunar Capital stocktake arrow down
% Change YTD
28.09% Lunar Capital increasesymbol
Index / Fund / Rate
S&P 500
Start of Year
3 840
Last Week
4 309
This Week
4 328 Lunar Capital increasesymbol
% Change YTD
12.70% Lunar Capital increasesymbol
Index / Fund / Rate
Prime Lending Rate
Start of Year
10.50%
Last Week
11.75%
This Week
11.75%
% Change YTD
11.90% Lunar Capital increasesymbol
Index / Fund / Rate
USD/ZAR
Start of Year
16.98
Last Week
19.34
This Week
19.01 Lunar Capital stocktake arrow down
% Change YTD
11.96% Lunar Capital increasesymbol
Index / Fund / Rate
EUR/ZAR
Start of Year
18.44
Last Week
20.49
This Week
19.98 Lunar Capital stocktake arrow down
% Change YTD
8.35% Lunar Capital increasesymbol
Index / Fund / Rate
Brent Crude ($'barrel)
Start of Year
85.95
Last Week
84.56
This Week
91.12 Lunar Capital increasesymbol
% Change YTD
6.02% Lunar Capital increasesymbol
Source: Iress

Click here to access your account to view statements, obtain tax certificates, add or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

Birken’s Stock Read More »

Ozempic: Unintended Consequences

Ozempic: Unintended Consequences

As new technologies and innovations are developed and widely implemented, a range of unintended consequences inevitably ensue. Last week, Walmart revealed that individuals purchasing weight loss medications containing semaglutide, such as Wegovy and Ozempic, at Walmart’s pharmacies have been purchasing slightly fewer groceries at its outlets. This development caused about a 2% drop in Walmart’s stock price. Other grocery retailers, fast-food chains, and sugary beverage manufacturers like McDonald’s and Coca-Cola also experienced declines in their respective share prices due to the announcement.

New innovations bring about new innovations. Ozempic, developed by Novo Nordisk, received approval from the Food and Drug Administration (FDA) in 2017 for the treatment of type-2 diabetes. Subsequently, it was observed that the drug was effective in treating individuals grappling with obesity. In 2021, Wegovy gained FDA approval specifically for obesity treatment. Wegovy and Ozempic operate as glucagon-like-peptide-1 (GPL-1) receptor agonist, essentially emulating the naturally occurring hormone GLP-1, which aids in appetite regulation and decelerates food digestion. This year, Novo Nordisk made the noteworthy discovery that their Wegovy treatment also reduces the risk of serious cardiovascular events in patients. The innovation of one drug has been able to treat people with different conditions.

As evidenced by Walmart’s recent announcement, new innovations exert influence on consumers across various dimensions. In the case of Ozempic, it was approved for treating diabetes; and subsequently observed to also treat obesity. Now, it is observed that the treatment for obesity results in a lower demand for food and beverage products.

These phenomena are highly interesting for investors:

  • ·Businesses who innovate in one product or service; but this leads to other innovations. Examples includes: Google starting as a search engines, now one of the largest advertising and content platforms in the world; Amazon starting as an on-line book stores; now one of the largest retailers in the world and a leading cloud services. Businesses that are in tune to consumers changing demands will be able to benefit from the changing landscape.

  • A positive impact on one business may negatively impact others. Retailers who have lost market share to Amazon and other online retailers; less food consumed by patients being treated for obesity.

Investors need to consistently be on the look out for these positive and negatives trends.

Novo Nordisk, Walmart, and Amazon are held in the Lunar BCI World Wide Flexible fund. They are also held by Lunar Capital’s Offshore Portfolio clients.

Key Indicators
Index / Fund / Rate
Start of Year
Last Week
This Week
% Change YTD
Index / Fund / Rate
Lunar BCI WW Flexible Fund
Start of Year
141.43
Last Week
173.87
This Week
176.38
% Change YTD
24.66% Lunar Capital increasesymbol
Index / Fund / Rate
JSE ALSI
Start of Year
73 049
Last Week
73 399
This Week
71 657 Lunar Capital stocktake arrow down
% Change YTD
-1.91% Lunar Capital stocktake arrow down
Index / Fund / Rate
NASDAQ Composite
Start of Year
10 467
Last Week
13 212
This Week
13 431 Lunar Capital increasesymbol
% Change YTD
28.32% Lunar Capital increasesymbol
Index / Fund / Rate
S&P 500
Start of Year
3 840
Last Week
4 321
This Week
4 309 Lunar Capital stocktake arrow down
% Change YTD
12.20% Lunar Capital increasesymbol
Index / Fund / Rate
Prime Lending Rate
Start of Year
10.50%
Last Week
11.75%
This Week
11.75%
% Change YTD
11.90% Lunar Capital increasesymbol
Index / Fund / Rate
USD/ZAR
Start of Year
16.98
Last Week
18.75
This Week
19.34 Lunar Capital increasesymbol
% Change YTD
13.90% Lunar Capital increasesymbol
Index / Fund / Rate
EUR/ZAR
Start of Year
18.44
Last Week
20.01
This Week
20.49 Lunar Capital increasesymbol
% Change YTD
11.12% Lunar Capital increasesymbol
Index / Fund / Rate
Brent Crude ($'barrel)
Start of Year
85.95
Last Week
93.60
This Week
84.56 Lunar Capital stocktake arrow down
% Change YTD
-1.62% Lunar Capital stocktake arrow down
Source: Iress

Click here to access your account to view statements, obtain tax certificates, add or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

Ozempic: Unintended Consequences Read More »

The Hard Truth about Pivoting (Part 2): Electric Vehicles

Much like Disney in the media industry, traditional motor vehicle companies are also encountering comparable challenges to pivot their businesses from ICE (internal combustion engine) to EVs (electric vehicles). As technologies advance, they open doors for the creation of new products through more cost-effective methods. Established businesses must adapt their strategies or risk losing market share or even facing extinction.

Toyota, VW, and Mercedes have traditionally focused on producing ICE vehicles. However, they now find themselves at a juncture where EVs are gaining traction. This shift is driven by improvements in battery range, reduced charge times, and more affordable production costs. Nevertheless, EVs are still in the early stages of capturing market share. In 2021, only 8.6% of new cars sold worldwide were EVs. The transition from ICE to EVs in the new car sales market is on an upward trajectory. These established car manufacturers must continue to service and innovate in the ICE segment while also striving to carve out a share in the growing EV market. Striking this balance can be a challenging task, especially when resources and attention are stretched in both directions.

American Tesla and Chinese BYD are exclusively dedicated to the Electric Vehicle (EV) market. Their primary goal is to secure the largest possible share of the EV market and enhance its appeal to consumers. They achieve this by refining their expertise in producing more affordable vehicles and establishing charging station infrastructure in pivotal markets to make the charging process more convenient for their customers.

The impact of emerging technologies extends beyond the realm of Electric Vehicle (EV) and Internal Combustion Engine (ICE) companies. It ripples through various industries that depend on the demand for these vehicles. EVs presently demand less maintenance, and when needed, it’s typically handled by electricians rather than traditional mechanics. They also rely more heavily on semiconductors due to their electric components, lithium for their batteries, and software for safety and autonomous driving. The shift from ICE to EV will create opportunities for businesses to thrive and capitalize on this trend.

Key Indicators
Index / Fund / Rate
Start of Year
Last Week
This Week
% Change YTD
Index / Fund / Rate
Lunar BCI WW Flexible Fund
Start of Year
141.43
Last Week
173.87
This Week
173.43
% Change YTD
22.63% Lunar Capital increasesymbol
Index / Fund / Rate
JSE ALSI
Start of Year
73 049
Last Week
73 399
This Week
72 383 Lunar Capital stocktake arrow down
% Change YTD
-0.91% Lunar Capital stocktake arrow down
Index / Fund / Rate
NASDAQ Composite
Start of Year
10 467
Last Week
13 212
This Week
13 219 Lunar Capital increasesymbol
% Change YTD
26.29% Lunar Capital increasesymbol
Index / Fund / Rate
S&P 500
Start of Year
3 840
Last Week
4 321
This Week
4 288 Lunar Capital stocktake arrow down
% Change YTD
11.67% Lunar Capital increasesymbol
Index / Fund / Rate
Prime Lending Rate
Start of Year
10.50%
Last Week
11.75%
This Week
11.75%
% Change YTD
11.90% Lunar Capital increasesymbol
Index / Fund / Rate
USD/ZAR
Start of Year
16.98
Last Week
18.75
This Week
18.92 Lunar Capital increasesymbol
% Change YTD
11.43% Lunar Capital increasesymbol
Index / Fund / Rate
EUR/ZAR
Start of Year
18.44
Last Week
20.01
This Week
20.00 Lunar Capital stocktake arrow down
% Change YTD
8.46% Lunar Capital increasesymbol
Index / Fund / Rate
Brent Crude ($'barrel)
Start of Year
85.95
Last Week
93.60
This Week
92.26 Lunar Capital stocktake arrow down
% Change YTD
7.34% Lunar Capital increasesymbol
Source: Iress

Click here to access your account to view statements, obtain tax certificates, add or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

The Hard Truth about Pivoting (Part 2): Electric Vehicles Read More »

The Hard Truth about Pivoting

As new technologies emerge, they provide opportunities for new ways of working, new products and services, or even cheaper ways to produce and deliver goods and services. This poses a challenge for incumbent businesses that need to pivot their businesses or face losing market share or even extinction.

These incumbent businesses must strike a delicate balance between tending to their current client base, as these clients typically contribute the most to the company’s cash flow. Simultaneously, they must innovate and leverage evolving technologies and consumer demands to safeguard against potential disruption from new market entrants. Despite their relative youth and small or no market share, new entrants hold an advantage over established companies; they can focus their resources and attention on the new product or service or a cheaper way to produce and deliver goods and services.

Disney has witnessed a decline in the value of their traditional linear TV assets recently due to the rise of streaming. Despite this, these assets continue to generate profits for Disney. Consumers now prefer on-demand content with flexible cancellation terms. In late 2019, Disney launched its streaming service to compete with streaming giants like Netflix and Amazon Prime. Initially relying on their extensive catalog, Disney soon realized that creating fresh content was essential to attract more subscribers and turn their streaming service profitable. Consequently, Disney has invested heavily in producing new content. However, some of their shows, like Marvel’s Secret Invasion, haven’t performed as well as anticipated, despite a substantial budget of around $200 million. This could be attributed to various factors, including consumers feeling the pinch of rising inflation or potentially experiencing fatigue from the constant influx of superhero movies and shows. Disney’s share price ended Friday at $81.25, roughly the same as what it was at the beginning of 2014.

The streaming revolution, pioneered by Netflix, has revolutionized numerous facets of the film and television industry. This encompasses changes in viewer habits, metrics for gauging show success, remuneration structures for industry professionals, and the financing models for shows.

Previously, a film’s triumph was gauged by its box office revenue, but now, success hinges on the inflow of new subscribers to a streaming platform. This can prove challenging to quantify, as subscribers may join for several different shows. Additionally, production expenses for films and TV shows have skyrocketed. The heightened demand for content from production companies has led to escalating costs. This has elevated the risk of platforms struggling to gain sufficient subscribers to offset these substantial expenses.

The streaming battle is fierce, and it’s far from over. Platforms are actively exploring strategies to carve out their unique niches and establish sustainable cash flows. Companies are not only vying against each other but also contending for consumers’ screen time, facing competition from giants like YouTube (owned by Alphabet) and gaming companies like Sony. Fortunes can shift swiftly if companies fail to produce content that resonates with viewers, as demonstrated by Disney’s recent experience.

Amazon is held in the Lunar BCI Worldwide Flexible Fund. It is also held by Lunar Capital’s offshore portfolio clients.

Key Indicators
Index / Fund / Rate
Start of Year
Last Week
This Week
% Change YTD
Index / Fund / Rate
Lunar BCI WW Flexible Fund
Start of Year
141.43
Last Week
181.74
This Week
173.87
% Change YTD
22.94% Lunar Capital increasesymbol
Index / Fund / Rate
JSE ALSI
Start of Year
73 049
Last Week
74 590
This Week
73 399 Lunar Capital stocktake arrow down
% Change YTD
0.48% Lunar Capital increasesymbol
Index / Fund / Rate
NASDAQ Composite
Start of Year
10 467
Last Week
13 708
This Week
13 212 Lunar Capital stocktake arrow down
% Change YTD
26.22% Lunar Capital increasesymbol
Index / Fund / Rate
S&P 500
Start of Year
3 840
Last Week
4 450
This Week
4 321 Lunar Capital stocktake arrow down
% Change YTD
12.52% Lunar Capital increasesymbol
Index / Fund / Rate
Prime Lending Rate
Start of Year
10.50%
Last Week
11.75%
This Week
11.75%
% Change YTD
11.90% Lunar Capital increasesymbol
Index / Fund / Rate
USD/ZAR
Start of Year
16.98
Last Week
19.01
This Week
18.75 Lunar Capital stocktake arrow down
% Change YTD
10.42% Lunar Capital increasesymbol
Index / Fund / Rate
EUR/ZAR
Start of Year
18.44
Last Week
20.21
This Week
20.01 Lunar Capital stocktake arrow down
% Change YTD
8.51% Lunar Capital increasesymbol
Index / Fund / Rate
Brent Crude ($'barrel)
Start of Year
85.95
Last Week
94.06
This Week
93.60 Lunar Capital stocktake arrow down
% Change YTD
8.90% Lunar Capital increasesymbol
Source: Iress

Click here to access your account to view statements, obtain tax certificates, add or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

The Hard Truth about Pivoting Read More »

Inditex: Changing Zara’s Fashion

Inditex, the parent company of the fashion brand Zara, is known for its innovative approach and willingness to challenge prevailing norms. They are recognized for employing a vertical integration business model, enabling them to conceptualise, design, manufacture, and stock clothing and homeware for sale in a matter of a few weeks. The company is dedicated to finding ways to actively engage with consumers who are looking for a seamless, on-demand experience.

Inditex is set to unveil their largest Zara outlet globally in Rotterdam. They’re also in the process of expanding the capacities of their other sizable stores, while phasing out a number of their underperforming smaller ones. This strategy stands in contrast to the trend seen among other fashion retailers, who are inclined towards smaller outlets to cut down on expenses. Zara’s objective is to accommodate their growing product range, such as homeware and sportswear; while also integrating these physical stores into Zara’s e-commerce operations. These outlets will also serve as compact warehouses and they will allow customers to collect or return online purchases at these locations.

Zara, like several other fashion brands, leverages their stores as a means to immerse consumers in their unique vision. However, this approach carries a potential risk. Bigger stores in expensive retail locations to be used for warehousing, could result in Zara paying more per square metre in storage costs compared to other businesses that use out-of-town warehouses.. This decision may not necessarily translate into increased customer foot traffic and usage of the stores beyond their initial intent.

Last week, Inditex released their half year results for 2023. Net sales increased by 16.6% to €16.8 billion. However, net income increased by 39%. This was primarily as a result of Inditex’s operating expenses, along with the depreciation and amortisation expenses, increasing at a lower rate compared to their sales growth. The net income margin for Inditex was 14.9% this half, compared to 12.1% a year ago.

Inditex is held by Lunar Capital’s offshore Portfolio Clients.

Key Indicators
Index / Fund / Rate
Start of Year
Last Week
This Week
% Change YTD
Index / Fund / Rate
Lunar BCI WW Flexible Fund
Start of Year
141.43
Last Week
175.87
This Week
179.66
% Change YTD
28.50% Lunar Capital increasesymbol
Index / Fund / Rate
JSE ALSI
Start of Year
73 049
Last Week
73 653
This Week
74 590 Lunar Capital increasesymbol
% Change YTD
2.11% Lunar Capital increasesymbol
Index / Fund / Rate
NASDAQ Composite
Start of Year
10 467
Last Week
13 591
This Week
14 031 Lunar Capital increasesymbol
% Change YTD
30.97% Lunar Capital increasesymbol
Index / Fund / Rate
S&P 500
Start of Year
3 840
Last Week
4 457
This Week
4 450 Lunar Capital stocktake arrow down
% Change YTD
15.89% Lunar Capital increasesymbol
Index / Fund / Rate
Prime Lending Rate
Start of Year
10.50%
Last Week
11.75%
This Week
11.75%
% Change YTD
11.90% Lunar Capital increasesymbol
Index / Fund / Rate
USD/ZAR
Start of Year
16.98
Last Week
19.13
This Week
19.01 Lunar Capital stocktake arrow down
% Change YTD
11.96% Lunar Capital increasesymbol
Index / Fund / Rate
EUR/ZAR
Start of Year
18.44
Last Week
20.45
This Week
20.21 Lunar Capital stocktake arrow down
% Change YTD
9.60% Lunar Capital increasesymbol
Index / Fund / Rate
Brent Crude ($'barrel)
Start of Year
85.95
Last Week
90.27
This Week
94.06 Lunar Capital increasesymbol
% Change YTD
9.44% Lunar Capital increasesymbol
Source: Iress

Click here to access your account to view statements, obtain tax certificates, add or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

Inditex: Changing Zara’s Fashion Read More »

Shoprite: Fuel for Thought

08 September 2023

Key Indicators

Index / Fund / Rate Start of Year Last week This Week % change YTD
Lunar BCI WW Flexible Fund 141.43 179.66 181.20 28.12%
JSE ALSI 73 049 74 787 73 653 0.83%
NASDAQ Composite 10 467 14 032 13 762 31.48%
S&P 500 3 840 4 516 4 457 16.08%
Prime Lending Rate 10,50% 11.75% 11.75% 11.90%
USD/ZAR 16,98 18.85 19.13 12.66%
EUR/ZAR 18,44 20.31 20.45 10.90%
Brent Crude ($’barrel) 85,95 88.92 90.27 5.03%

Source: Iress

Weekly Stocktake with Danyaal

Shoprite: Fuel for Thought

Shoprite, the grocery retailer, has seen a consistent rise in market share in recent years. The latest results for 2023 demonstrate the success of their expansion efforts. Sales for the Shoprite group in 2023 increased by 17.1%, reaching a total revenue of R219.5 billion. Despite a high inflationary environment, Shoprite’s gross profit also saw a notable rise, reaching R51.7 billion for the year. However, the overall profit for the year saw a more modest increase of 2.8% to R5.9 billion, mainly attributed to diesel costs incurred during loadshedding and delays in finalising the acquisition from Makro.

Shoprite’s results provide valuable insights into the true state of the economy. Through their Xtra Savings loyalty program, Shoprite gathers extensive data, boasting 10.6 million participants in the Checkers program and 17.2 million in the Shoprite program. This enables Shoprite to gain a thorough understanding of individual buying habits and their evolution over time. Given the challenging economic conditions, consumers have been actively seeking better prices. Shoprite has addressed this by offering cost-effective bundled deals to consumers.

Upon the release of the results, a notable focal point was the diesel cost for Shoprite’s group, amounting to R1.3 billion for the year. This marks a significant increase from the R0.2 billion spent the previous year. Retailers generally operate on narrow profit margins, with Shoprite’s net margin standing at 2.7% for the year. Retailers contend with the dual-edged impact of operational leverage. Efficiency improvements in their operations have an amplified effect on net profit in relative terms. Conversely, factors like the increase in diesel costs have a substantial negative impact. The diesel costs shaved 18% off Shoprite’s potential profits.

During the earnings call, there was limited discussion regarding plans for the implementation of long-term power solutions, such as solar. One possible reason could be that Shoprite leases the properties it utilizes from third parties, like shopping malls. Thus, negotiating lease agreements with property owners may be the stumbling block.

At Lunar Capital, we like Shoprite. We believe that their recent results reflect positively on their ability to engage with customers across various income brackets. Their emphasis on expansion, coupled with their efficient central distribution model, allows them to maintain competitive pricing for consumers.

Connect with us on social media:

Lunar Capital on Eastwave Radio

Every Tuesday, at 07h45, Sabir chats with Nazia from Eastwave Radio (92.2 fm, live stream on www.eastwave.co.za) on investing and the markets.

Click here to access your account to view statements, obtain tax certificates, add, or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

Shoprite: Fuel for Thought Read More »

Lululemon: Stretching Legs Internationally

1 September 2023

Key Indicators

Index / Fund / Rate Start of Year Last week This Week % change YTD
Lunar BCI WW Flexible Fund 141.43 175.87 179.66 27.03%
JSE ALSI 73 049 73 836 74 787 2.38%
NASDAQ Composite 10 467 13 591 14 031 34.05%
S&P 500 3 840 4 406 4 516 17.60%
Prime Lending Rate 10,50% 11.75% 11.75% 11.90%
USD/ZAR 16,98 18.63 18.82 10.84%
EUR/ZAR 18,44 20.10 20.31 10.14%
Brent Crude ($’barrel) 85,95 84.89 89.08 3.64%

Source: Iress

Weekly Stocktake with Danyaal

Lululemon: Stretching Legs Internationally

Last week, Lululemon released their Q2 2023 results. Despite the slowdown in consumer spending due to the tough economic environment worldwide, Lululemon increased their revenue by 18% compared to the same period last year. For the quarter, sales in the US accounted for 64% of total sales. The gross margin and net income margin for Lululemon came in at 58.8% and 15.4%, respectively. Lululemon’s price to earnings ratio closed at 52.5 on Friday. This is still quite a high valuation.

Lululemon is an athleisure retailer and has a more established presence in the US compared to other parts of the world. However, their growth outside the US is much higher at 52% versus 11% in the US. The international sales surge was primarily fuelled by a notable revenue increase in China, which witnessed a 61% growth rate. China currently boasts the second-largest number of Lululemon stores, totalling 126 as of the end of July 2023. These stores in China tend to be smaller, and the company offers its products at lower prices in response to the smaller average wallet size of customers in the region. Consequently, the average revenue per store in China is lower, currently standing at $2.2 million per a store for the quarter, compared to the US, where the average is $3.9 million.

The stores serve as essential platforms for Lululemon to showcase their products and create unique user experiences for customers. Notably their direct-to-consumer segment has become increasingly significant, accounting for 40% of their total sales. Revenue derived from this segment increased by 15% compared to the same quarter last year, while revenue from their physical stores grew by 21%. The operating income margin for the direct-to-consumer segment is higher at 42%, whereas the stores segment has an operating income margin of 30%.

Lululemon operates in a highly competitive landscape, facing rivals such as Nike and other legacy luxury fashion companies such as Louis Vuitton (LVMH). Both Nike and LVMH boast well-established positions and robust balance sheets. Nevertheless, Lululemon’s relatively focused product line-up provides them with the potential to expand into diverse product categories. The barriers to entry in the retail world are comparatively lower than in other industries, meaning new potential competitors are coming into the market every day. Despite these challenges, Lululemon maintains a dedicated and loyal customer base. Customers repeatedly return to purchase their products due to the consistent quality they offer.

Lululemon is held in the Lunar BCI Worldwide Flexible Fund. Lululemon and LVMH are held by Lunar Capital’s Offshore Portfolio Clients.

Connect with us on social media:

Lunar Capital on Eastwave Radio

Every Tuesday, at 07h45, Sabir chats with Nazia from Eastwave Radio (92.2 fm, live stream on www.eastwave.co.za) on investing and the markets.

Click here to access your account to view statements, obtain tax certificates, add, or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

Lululemon: Stretching Legs Internationally Read More »

Nvidia: Where to from Here?

25 August 2023

Key Indicators

Index / Fund / Rate Start of Year Last week This Week % change YTD
Lunar BCI WW Flexible Fund 141.43 176.65 175.87 24.35%
JSE ALSI 73 049 73 081 73 836 1.08%
NASDAQ Composite 10 467 13 291 13 591 29.84%
S&P 500 3 840 4 370 4 406 14.73%
Prime Lending Rate 10,50% 11.75% 11.75% 11.90%
USD/ZAR 16,98 19.01 18.63 9.72%
EUR/ZAR 18,44 20.67 20.10 9.00%
Brent Crude ($’barrel) 85,95 84.79 84.89 -1.23%

Source: Iress

Weekly Stocktake with Danyaal

Nvidia: Where to from Here?

Nvidia released the most anticipated results of the earnings season last week. Since the beginning of the year, Nvidia’s stock price has increased over 220% which resulted in their market capitalisation reaching $1.1 trillion by Friday last week. During the year, the market became ever-more optimistic about Nvidia. For the recent quarter, revenue increased by 101% to $13.5 billion compared to the same quarter last year, with the gross profit margin reaching 70%. Nvidia’s quarterly net profit increased by 843% to $6.18 billion.

The primary cause behind these results largely stemmed from Nvidia’s sales of Graphic Processing Units (GPUs) used in AI (Artificial Intelligence) data centres. The main buyers of these products include Alphabet, Microsoft, and Amazon; all of which already had extensive data centre infrastructures. The most sort after chip for AI infrastructure is Nvidia’s H100 chip, which costs around $40,000. Since ChatGPT’s debut last year, companies have been adjusting their budgets to accommodate AI expenditure. These tech companies have been allocating substantial resources to acquire these chips so that they can try get ahead in the AI race.

Although Nvidia performed strongly this quarter, there are concerns about the sustainability of these results, and the strategies that companies will implement to provide AI services. Microsoft, who owns a stake in OpenAI (the creators of ChatGPT) have recently incorporated Large Language Models (LLMs) in some of their products such as Office365. In terms of hard numbers, the long-term implications of this implementation still remains unclear. Investors will be looking for concrete returns on investment on AI spending. Without adequate returns, AI infrastructure spending will reduce, impacting the share prices of companies like Nvidia.

Nvidia, Microsoft and Amazon are held in the Lunar BCI Worldwide Flexible Fund. They are also held by Lunar Capital’s Offshore Portfolio Clients.

Connect with us on social media:

Lunar Capital on Eastwave Radio

Every Tuesday, at 07h45, Sabir chats with Nazia from Eastwave Radio (92.2 fm, live stream on www.eastwave.co.za) on investing and the markets.

Click here to access your account to view statements, obtain tax certificates, add, or make changes to your investments.

Our email address is: [email protected]

Disclosures
Lunar Capital (Pty) Ltd is a registered Financial Services Provider. FSP (46567)
Read our full Disclosure statement: https://lunarcapital.co.za/disclosures/
Our Privacy Notice: https://lunarcapital.co.za/privacy-policy/
The Lunar BCI Worldwide Flexible Fund Fact Sheet  can be read here.
This stocktake is prepared for the clients of Lunar Capital (Pty) Ltd. This stocktake does not constitute financial advice and is generated for information purposes only.

Nvidia: Where to from Here? Read More »

Scroll to Top